Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease

Respiratory Medicine

Volumn 103, Issue 8, 2009, Pages 1152-1158

  Mittoo, Shikha ^a   Gelber, Allan C ^b   Christopher Stine, Lisa ^b   Horton, Maureen R ^b   Lechtzin, Noah ^b   Danoff, Sonye K ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinuclear antibody; Collagen vascular disease; Interstitial lung disease; Pulmonary fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COLLAGEN DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOLOGICAL MARKERS; COLLAGEN DISEASES; CREATINE KINASE; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES;

EID: 67649379349     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.02.009     Document Type: Article

References (30)

1. Lambkin C., Bergin C., Sealers T., and Waller B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J 32 Suppl (2001) S69-S80
2. Highland K.B., and Silver R.M. New developments in scleroderma interstitial lung disease. Curr Opin Rheumatol 17 6 (2005) 737-745
3. Frazier A.R., and Miller R.D. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 65 4 (1974) 403-407
4. Estes D., and Christian C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50 2 (1971) 85-95
5. Steen V.D., Conte C., Owens G.R., and Medsger Jr. T.A. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37 9 (1994) 1283-1289
6. Metafratzi Z.M., Georgiadis A.N., Ioannidou C.V., Alamanos Y., Vassiliou M.P., Zikou A.K., et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 36 5 (2007) 338-344
7. Turner-Warwick M., and Haslam P. Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies. Clin Allergy 1 1 (1971) 83-95
8. Kinder B.W., Collard H.R., Koth L., Daikh D.I., Wolters P.J., Elicker B., et al. Idiopathic NSIP: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 176 7 (2007) 691-697
9. Sato T., Fujita J., Yamadori I., Ohtsuki Y., Yoshinouchi T., Bandoh S., et al. Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders. Rheumatol Int 26 6 (2006) 551-555
10. Kim E.A., Lee K.S., Johkoh T., Kim T.S., Suh G.Y., Kwon O.J., et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 22 Spec no (2002) S151-S165
11. Nakamura Y., Chida K., Suda T., Hayakawa H., Iwata M., Imokawa S., et al. Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 20 3 (2003) 235-241
12. Flaherty K.R., Thwaite E.L., Kazerooni E.A., Gross B.H., Toews G.B., Colby T.V., et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 58 2 (2003) 143-148
13. Flaherty K.R., Toews G.B., Lynch III J.P., Kazerooni E.A., Gross B.H., Strawderman R.L., et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 110 4 (2001) 278-282
14. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165 2 (2002) 277-304
15. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 3 (1988) 315-324
16. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292 7 (1975) 344-347
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23 5 (1980) 581-590
18. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33 8 (1990) 1101-1107
19. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 11 (1982) 1271-1277
20. itali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36 3 (1993) 340-347
21. Mosca M., Neri R., Bencivelli W., Tavoni A., and Bombardieri S. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years. J Rheumatol 29 11 (2002) 2345-2349
22. Mosca M., Neri R., and Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17 5 (1999) 615-620
23. Poormoghim H., Lucas M., Fertig N., and Medsger Jr. T.A. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 43 2 (2000) 444-451
24. Belle F.L.G.V. Biostatistics: a methodology for the health sciences (1993), John Wiley & Sons Inc, New York
25. Cottin V. Interstitial lung disease: are we missing formes frustes of connective tissue disease?. Eur Respir J 28 5 (2006) 893-896
26. Coultas D.B., Zumwalt R.E., Black W.C., and Sobonya R.E. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150 4 (1994) 967-972
27. Park J.H., Kim D.S., Park I.N., Jang S.J., Kitaichi M., Nicholson A.G., et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175 7 (2007) 705-711
28. Flaherty K.R., Colby T.V., Travis W.D., Toews G.B., Mumford J., Murray S., et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167 10 (2003) 1410-1415
29. Hesselstrand R., Scheja A., Shen G.Q., Wiik A., and Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 42 4 (2003) 534-540
30. Collard H., Curran-Everett D., Fischer A., and Brown K.K. Predictive value of screening rheumatoid factor and anti-nuclear antibody testing in patients presenting with interstitial lung disease. Proc Am Thoracic Soc 3 (2006) A722